CDSCO monthly lab alert
CDSCO NSQ alert, June 2024: 61 drug batches flagged
By Blacklisted editorial team· Published 20 Jul 2024· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its June 2024 alert, the Central Drugs Standard Control Organisation listed 61 drug batches that failed quality tests, 31 at central laboratories and 30 at state drug-testing laboratories, from 57 manufacturers across 58 products. The most common failure was dissolution, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Yogarajaguggulu, VolKast Kid Syrup 60 ml., Virpan-40.
61
Batches flagged
31 / 30
Central / state labs
Dissolution
Top reason
57
Manufacturers
Batches per month, last 12 alerts
Jul 2023Jun 2024 · 61
Full list of NSQ batches, June 2024
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Yogarajaguggulu | 209/21Mfg 2022-03 · Exp 2025-03 | Bhaskaravilasam VaidyasalaKerala | It fails the test ?Alcohol soluble Extractive and pH? as per APIpH | DTL ThiruvananthapuramState lab |
| VolKast Kid Syrup 60 ml. | ABS- 2301022Mfg 2023-01 · Exp 2024-12 | Amentis Biotech Pvt. Ltd | CONTENT OF MONTELUKAST AND LEVOCETIRIZINE GYDROCHLORIDE IN THE SAMPLE IS LESS (i.e. MONTELUKAST IS 10.50% AND LEVOCETIRIZINE HYDROCHLORIDE IS 71.88% OF THE STATED AMOUNT) THAN THE PERMISSIBLE LIMITS.Other | State Lab MaharashtraState lab |
| Virpan-40 | T-2306031AMfg 2023-06 · Exp 2025-05 | WHITE ENGLE LABORATORIES | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION IN BUFFER STAGE.Dissolution | State Lab MaharashtraState lab |
| Tranexamic Acid Tablets I.P. 500 mg | GT31022Mfg 2024-01 · Exp 2025-12 | OMEGA PHARMA KhasraNo.-482Uttarakhand | Related substancesRelated substances | CDTL MumbaiCDSCO lab |
| SOFTOM-D Omeprazole and Domperidone Capsules IP | UD2C- 23252BMfg 2023-04 · Exp 2025-03 | ULTRA DRUGS PVT. LTD. (UNIT-II) | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).Dissolution | State Lab MaharashtraState lab |
| Rosumep ASP 10/75mg Capsules | PBWGM04Mfg 2023-09 · Exp 2025-08 | Pure & Care Healthcare Pvt. Ltd | THE SAMPLE DOES NOT COMPLY WITH IP FOR THE TEST ?RELATED SUBSTANCES ? ROSUVASTATIN?.Related substances | State Lab MaharashtraState lab |
| Ranitidine Hydrochloride Tablets (Ranylaj-150) | GTDE3019Mfg 2023-05 · Exp 2025-04 | Francis Remdies (India) Pvt.LtdUttarakhand | DescriptionDescription | CDL KolkataCDSCO lab |
| RABEPP TABLETS (Rabeprazole Sodium Tablets IP) | ATG2K135Mfg 2022-11 · Exp 2024-10 | ANROSE PHARMA | CONTENT OF RABEPRAZOLE SODIUM IM THE SAMPLE IS LESS (65.04% OF THE LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT 90.0% - 110.0%)Labelling | State Lab MaharashtraState lab |
| Propylene Glycol USP/IP | BT1205B0 4072023Mfg 2023-07 · Exp 2024-07 | Balaji Amines Limited | Relative DensityOther | CDL KolkataCDSCO lab |
| Propylene Glycol USP | 97220141 13Mfg 2023-11 · Exp 2028-10 | Shell Eastern Chemicals | Specific GravityOther | CDL KolkataCDSCO lab |
| Propylene Glycol I.P. | PG- IP/2023- 24/2355Mfg 2023-11 · Exp 2028-10 | Manali Petrochemicals LtdTamil Nadu | Relative DensityOther | CDL KolkataCDSCO lab |
| Prednisolone Tablets IP 10 mg | PRDT- 1007Mfg 2024-11 · Exp 2024-10 | WINGS BIOTECH LLPHimachal Pradesh | Assay of PrednisoloneAssay | RDTL ChandigarhCDSCO lab |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg. | PGR-07Mfg 2024-01 · Exp 2025-12 | Agron Remedies Pvt. LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Pantakos-40 (Pantoprazole Gastro-resistant Tablets IP ) | CCT231092 BMfg 2023-09 · Exp 2025-08 | Cent Cure Pvt Ltd | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION IN BUFFER STAGE.Dissolution | State Lab MaharashtraState lab |
| PANTOPRAZOLE (EC) & DOMPERIDONE (SR) CAPSULES IP (PANTIAC-DSR) | PTRC-149Mfg 2023-02 · Exp 2025-01 | IOSIS REMEDIES PVT. LTD | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE) .Dissolution | State Lab MaharashtraState lab |
| Oseltamivir Cap IP 75 mg | D 0444/24- 25Mfg ? · Exp ? | Supplied by Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP standard with respect to the ?Descriptive part? of hard gelatin capsulesOther | DTL ThiruvananthapuramState lab |
| Omeford - 40 | SNT-220421Mfg 2022-09 · Exp 2024-08 | SVR HEALTHCARE (A GMP Certified Company) | THE CONTENT OF OMEPRAZOLE IN THE SAMPLE IS LESS (l.e. 40.84% OF LABELLED AMOUNT) THAN THE SCHEDULE V LIMITSLabelling | State Lab MaharashtraState lab |
| OMEPRAZOLE & DOMPERIDONE CAPSULES (REMIZOLE-D) | SPC230578 CMfg 2023-03 · Exp 2025-02 | SALUS PHARMACEUTICALS | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).Dissolution | State Lab MaharashtraState lab |
| Norfloxacin Oral Suspension (Ridnor Suspension) | RL230022Mfg 2023-03 · Exp 2025-02 | RIDLEY LIFE SCIENCE PVT. LTDDelhi | Description and Total Fungal CountDescription | RDTL ChandigarhCDSCO lab |
| Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (Levmont) | ST23- 384DMfg 2023-05 · Exp 2025-04 | Symbiosis Pharmaceuticals Pvt. LtdHimachal Pradesh | Dissolution of Montelukast Levocetirizine hydrochlorideDissolution | RDTL GuwahatiCDSCO lab |
| Mannitol Injection I.P. (20% w/v) | M1M30038Mfg 2023-07 · Exp 2025-06 | Kunal Remedies Pvt. LtdUttar Pradesh | Test for SterilitySterility | RDTL GuwahatiCDSCO lab |
| MONTOR -LC TABLET (MONTELUKAST SODIUM & LEVOCETRIZINE DIHYDROCHLORI DE TABLET I.P.) | B18523001Mfg 2023-01 · Exp 2024-12 | TORQUE PHARMACEUTICALS PVT. LTD | THE SAMPLE DOES NOT COMPLY WITH I P REQUIREMENTS FOR DISSOLUTION TESTDissolution | State Lab MaharashtraState lab |
| MONTICET-L Tablets ( Montelukast & Levocetirizine Hydrochloride Tablets) | TP-7581Mfg 2022-09 · Exp 2024-08 | TICOMA PHARMACIA | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST. THE SAMPLE IS OFFICIAL IN 1 P 2018 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE 96 OF THE DRUGS AND COSMETICS ACT 1940 AND RULES 1945.Dissolution | State Lab MaharashtraState lab |
| M2 Pan-DSR (Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP) | CWHC-283Mfg 2022-10 · Exp 2024-09 | COSWAY PHARMACEUTICALS | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION OF PANTOPRAZOLE AT ACID STAGEDissolution | State Lab MaharashtraState lab |
| Lytraco 200 Itraconazole Capsules 200 mg | SLP-22445Mfg 2023-02 · Exp 2025-01 | STERLIFE PHARMA PVT. LTD | THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TEST THE SAMPLE IS OFFICIAL IN B P 2021 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE 96 OF THE DRUGS AND COSMETICS ACT 1940 AND RULES 1945.Dissolution | State Lab MaharashtraState lab |
| Losartan Potassium Tablets IP 50 mg | HLOA06Mfg 2023-11 · Exp 2025-10 | Hindustan Antibiotics LtdHaryana | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab |
| Liquid Paraffin IP | EP4032Mfg 2024-01 · Exp 2026-12 | Repacked by :- Kerala State Drugs & Pharmaceuticals LtdKerala | It fails the test light absorption as per IPOther | DTL ThiruvananthapuramState lab |
| Levocetrizine Dihydrochloride & Montelukast Sodium Tablets I.P. Zeemont | T22H370CMfg 2022-08 · Exp 2024-07 | Bajaj Formulations | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST.Dissolution | State Lab MaharashtraState lab |
| Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP | 23112701Mfg 2023-03 · Exp 2025-02 | MERCURY LABORATORIES LIMITEDGujarat | Dissolution of MontelukastDissolution | RDTL GuwahatiCDSCO lab |
| Levetiracetam Tablets U.S.P.500 Mg (LEVEEG-500) | T23D050AMfg 2023-04 · Exp 2025-03 | BAJAJ FORMULATIONS | THE SAMPLE DOES NOT COMPLY WITH USP REQUIREMENTS FOR DISSOLUTION.Dissolution | State Lab MaharashtraState lab |
| Iron and Folic Acid Syrup IP | IFIS23015Mfg 2023-08 · Exp 2025-01 | Galpha Laboratories LimitedHimachal Pradesh | Assay of Folic AcidAssay | RDTL GuwahatiCDSCO lab |
| IRON & FOLIC ACID SYRUP IP | RIFS-209Mfg 2024-04 · Exp 2026-09 | Revat Laboratories Pvt. Ltd | pH and Assay of Folic AcidAssay | CDTL HyderabadCDSCO lab |
| INFI-650 TABLETS (PARACETAMOL TABLETS I.P. 650 mg) | AT-100008Mfg 2022-12 · Exp 2025-11 | ABARIS HEALTHCARE | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST.Dissolution | State Lab MaharashtraState lab |
| Haridrakhandam | 207/23Mfg 2024-03 · Exp 2026-02 | Bhaskaravilasam VaidyasalaKerala | It fails the test ?pH? as per APIpH | DTL ThiruvananthapuramState lab |
| Glipizide and Metformin Tablets IP (Glynase-MF) | 4010026Mfg 2023-11 · Exp 2025-04 | USV Private LimitedKarnataka | Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab |
| Gentamicin Sulphate Injection I.P. 2 ml | 323-216Mfg 2023-03 · Exp 2025-02 | Zee Laboratories LtdHimachal Pradesh | Description & Particulate matterDescription | CDL KolkataCDSCO lab |
| Frusemide Injection IP 2 ml (FRUSEMIDE) | FRA12347Mfg 2023-12 · Exp 2025-11 | Nandani Medical Laboratories Pvt. LtdMadhya Pradesh | pHpH | CDL KolkataCDSCO lab |
| Fexofenadine Hydrochloride Tablets IP (MANOFEX-180 TABLETS) | CT232407 15AMfg 2023-08 · Exp 2025-07 | CMG BIOTECH PVT. LTD | Dissolution (In 10 minutes) and (in 30 minutes)Dissolution | RDTL ChandigarhCDSCO lab |
| Extuss-D (Dextromethorp han HBR, Chlorpheniramin e Maleate & Phenylephrine HCL Syrup) | 2402168Mfg 2024-02 · Exp 2026-01 | Brij Healthcare Pvt. LtdGujarat | Assay of Phenylephrin e HydrochlorideAssay | CDTL MumbaiCDSCO lab |
| Exo Cheri (Dextromethorp han Hydrobromide Chlorpheniramin e Maleate Pheylephrine Hydrochloride Cough Syrup) | L/040618Mfg 2024-04 · Exp 2026-01 | Exotic PharmaGujarat | pHpH | CDTL MumbaiCDSCO lab |
| Etoricoxib Tablets I.P. 90 mg. | ECX-2304Mfg 2023-08 · Exp 2025-07 | Apple Formulations Private LimitedUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Etamsylat Tablets 500 mg | ELT1104Mfg 2024-02 · Exp 2024-07 | Unicure India LtdUttar Pradesh | DescriptionDescription | CDTL MumbaiCDSCO lab |
| Esomeprazole Gastro- Resistant Tablets IP 40 mg (Esomedge- 40) | GD23083Mfg 2023-07 · Exp 2025-06 | GlenSmith Labs Private LimitedUttarakhand | DissolutionDissolution | CDL KolkataCDSCO lab |
| ELTHROM-200 (Azithromycin oral suspension IP) 15ML | G-042/5045Mfg 2023-05 · Exp 2025-04 | ELFIN DRUGS PVT. LTD | CONTENT OF AZITHROMYCIN IN THE SAMPLE IS LESS (72.96% OF LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT-90.0%- 110.0%)Labelling | State Lab MaharashtraState lab |
| DYNACID SUSPENSION (aluminium, magnesium & simethicone oral suspension IP.) | BULH23008Mfg 2023-04 · Exp 2025-03 | Leeford Healthcare Ltd | 1) THE SAMPLE DOES NOT COMPLY WITH I.P. REQUIREMENTS FOR TOTAL AEROBIC VIABLE COUNT IN TEST FOR MICROBIAL CONTAMINATION. 2) TOTAL AEROBIC VIABLE COUNT OF THE SAMPLE IS 20993128 CFU/GM. (1.P. LIMIT-TOTAL AEROBIC VIABLE COUNT OF THE SAMPLE - NOT MORE THAN 100 CFU/GMMicrobial limits | State Lab MaharashtraState lab |
| DRPLAN-DSR (Pantoprazole Gasto-resistant & Domperidone Prolonged-release Capsules IP) | AC2209003AMfg 2022-09 · Exp 2024-08 | ADDII BIOTECH PVT. LTD | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE) .Dissolution | State Lab MaharashtraState lab |
| Compound Sodium Lactate Injection I.P., 500 ml (Ringer Lactate Solution for Injection) | P2401050 08Mfg 2024-01 · Exp 2025-12 | Vision Parenteral Pvt. Ltd | Bacterial endotoxinsBacterial endotoxins | CDL KolkataCDSCO lab |
| Co-trimoxazole Tablets IP (S- tron Tablets SS) | ST-223Mfg 2023-06 · Exp 2025-05 | High Tech PharmaMadhya Pradesh | Dissolution (Trimethopri m and Sulphametho xazole)Dissolution | RDTL GuwahatiCDSCO lab |
| Ceftriaxone for Injection I.P. 1 gm | DC30119Mfg 2023-10 · Exp 2025-09 | Captab Biotec Unit-IIHimachal Pradesh | Particulate matterParticulate matter | CDL KolkataCDSCO lab |
| Cefixime & Ofloxacin Tablets (CEFIKAM OF 200) | DB230057Mfg 2023-02 · Exp 2025-01 | Daxin Pharmaceuticals Pvt. LtdHimachal Pradesh | Assay of Cefixime Trihydrate & Assay OfloxacinAssay | CDL KolkataCDSCO lab |
| CUCID-DM | CDMC501Mfg 2023-05 · Exp 2025-04 | TULBROS FORMULATIONS | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR OMEPRAZOLE IN ACID STAGE.Dissolution | State Lab MaharashtraState lab |
| COZOL- D(Omeprazole with Domperidone Capsules) | AC1952Mfg 2023-07 · Exp 2025-06 | ALICON PHARMACEUTICAL PVT LTD | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE). THE SAMPLE IS OFFICIAL IN IP.Dissolution | State Lab MaharashtraState lab |
| CANDITRAL 100 (ITRACONAZOLE CAPSULE B.P. 100 MG) | 5230123Mfg 2023-01 · Exp 2025-06 | GLENMARK PHARMACEUTICALS LTD | THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TESTDissolution | State Lab MaharashtraState lab |
| Bacotil-200 [Cefpodoxime Proxetil Tablets USP ] | ZTB-148Mfg 2024-03 · Exp 2026-02 | Zenith Healthcare Ltd works: 388/34Gujarat | It fails the test ?Dissolution? as per USPDissolution | DTL ThiruvananthapuramState lab |
| Amoxycillin & Potassium Clavulanate Injection IP 1.2 gm | 23AP04Mfg 2023-05 · Exp 2025-04 | Sai Parenterals LimitedTelangana | Clarity of Solution and Assay of Potassium ClavulanateAssay | CDL KolkataCDSCO lab |
| Amloheart-AT [Amlodipine Besylate and Atenolol Tablets] | LE223030Mfg 2023-03 · Exp 2025-02 | Lividus Pharmaceuticals pvt.LtdTamil Nadu | It fails the test ?Assay? of Amlodipine BesylateAssay | DTL ThiruvananthapuramState lab |
| Alpracan 0.5 Tablets (Alprazolam Tablets) | T2455Mfg 2022-10 · Exp 2025-09 | Evolet Pharmaceutical Pvt. Ltd | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR ALPRAZOLAM TABLETS FOR THE DISSOLUTION TEST WITH RESPECT TO ABOVE PROTOCOL.Dissolution | State Lab MaharashtraState lab |
| Aloevera, Glycerin, Vitamin-E and Jojoba oil (Synmoist Soap) | COS-132Mfg 2024-03 · Exp 2026-02 | Samanyu Skin CareHimachal Pradesh | Matter insoluble in alocholOther | RDTL ChandigarhCDSCO lab |
| Aloevera, Glycerin and Vitamin-E Soap (D-Soft Soap) | COS-130Mfg 2024-03 · Exp 2026-02 | Samanyu Skin CareHimachal Pradesh | Matter insoluble in alocholOther | RDTL ChandigarhCDSCO lab |
| Aloevera+Glyce rin+Almond Oil and Vitamin-E Soap (Aqualux Soap) | COS-131Mfg 2024-03 · Exp 2026-02 | Samanyu Skin CareHimachal Pradesh | Matter insoluble in alocholOther | RDTL ChandigarhCDSCO lab |
| Albendazole Tablets IP | MS1AO22 01Mfg 2022-07 · Exp 2025-06 | MAXTAR BIO- GENICSHimachal Pradesh | DissolutionDissolution | RDTL ChandigarhCDSCO lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (61 rows). Revised CDSCO lists are diffed on each monthly rebuild.